High-level panel of Merck Foundation CEO, Senator Rasha Kelej, the First Lady of Sierra Leone, H.E. Mrs. FATIMA MAADA BIO and The Vice President of Liberia, H.E. Dr. Jewel Howard Taylor to discuss eff
Indonesia National Agency for Drug and Food Control, BPOM, Approved QDENGA(TAK-003) for Use in Individuals Six Years to 45 Years of Age1 QDENGAis the Only Dengue Vaccine Approved in Indonesia for Use
Medtronic Launches AI Powered GI Genius™ Module for Colonoscopy that Offers Enhanced Visualization for Detection of Colorectal Cancer in India
Achieved Global Recognition and Top Employer Certification in 22 Countries from Top Employers Institute − Global Recognition Reinforces Commitment to People and Outstanding People Policies Takeda (TS
Vaccines and Related Biological Products Advisory Committee will hold meeting on September 22, 2022 RBX2660 is an investigational microbiota-based live biotherapeutic studied for its potential to redu
Merck Foundation, the philanthropic arm of Merck KGaA Germany conducted their Annual Kenya Alumni Summit in Nairobi to discuss their programs with their partners and beneficiaries to transform patient
/newsonfloor/media/post_banners/BBaNSCV4NIgUXbDsVpJr.jpeg)
/newsonfloor/media/post_banners/OP4TGHUpfwE8HnDN7O1q.jpeg)
![Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Indonesia for Use Regardless of Prior Dengue Exposure](https://img-cdn.thepublive.com/fit-in/560x320/filters:format(webp)/newsonfloor/media/post_banners/KxvmBU83yvYyxhjYKE5z.jpg)
/newsonfloor/media/post_banners/QptjV2xI5gZZo78YzuRT.jpg)
/newsonfloor/media/post_banners/ufnAoqvsJt8crZrLmnvL.jpg)
/newsonfloor/media/post_banners/klDmnj0dtnBBDlMMbhJ6.jpeg)
/newsonfloor/media/post_banners/gJbIsUyKKhpUebqLrk17.jpeg)
/newsonfloor/media/post_banners/RnHO7Dq0mMVof0rtrt2G.jpg)
/newsonfloor/media/post_banners/FDMARIrZTfOcInOqMbxM.jpg)
